Dr. Samadi Talks About New Prostate Cancer Drug Warning Labels on FoxNews

Health, Public Policy

Dr. David Samadi appeared on FoxNew to discuss the new drug label warnings required by the FDA to labels on gonadotropin-releasing hormone (GnRH) agonists which are used to treat prostate cancer.

Dr. Samadi is the Medical Contributor to Talking About Men’s Health.  Learn more about Dr. Samadi or visit his website.

David Samadi, MD - Medical Contributor

View posts by David Samadi, MD - Medical Contributor
Dr. Samadi is a board-certified urologic oncologist trained in open and traditional and laparoscopic surgery and is an expert in robotic prostate surgery. He is chairman of urology, chief of robotic surgery at Lenox Hill Hospital and professor of urology at Hofstra North Shore-LIJ School of Medicine. He is a medical correspondent for the Fox News Channel's Medical A-Team. Learn more at roboticoncology.com. Visit Dr. Samadi's blog at SamadiMD.com. Follow Dr. Samadi on Twitter, Instagram, Pinterest, and Facebook.

Related Posts

  1. Closing the Gap: How You Can Make a Difference This Giving Tuesday and Beyond

    December 3, 2024

  2. “Daddy Blackbird:” A Story of Resilience and Healing, Unpacking Suicide’s Impact on Men and Their Families

    November 20, 2024

  3. Bridging the Empathy Gap in Health: A Call for Mutual Understanding and Compassion

    November 13, 2024
Scroll to top